1Sem.·

New position

I believe in $MRK (-4,87 %) even after Keytruda...


With the high R&D, I think things will continue positively

25.03
Merck & Co logo
Acheté x25 à 81,30 €
2 032,50 €
9
5 Commentaires

image de profil
Considering a savings plan at $MRK. Basically, of course, currently favorable in terms of P/E ratio, but the pipeline is really bad. Today I spent another 2 billion on a Chinese company... I don't have the faith for a high one-off amount at the moment.
2
image de profil
@Michey777 if there is strong positive news again, the share price will no longer be so favorable...
1
image de profil
@Puki may be. But does it apply to every share? In the end, we are now at around the level of the end of 2019...
image de profil
I'm also torn as to whether I should buy more 🤔
image de profil
Gardasil is the problem child, but 30 Phase III and 50 Phase II projects and a 3% dividend speak in favor of buying it
1
Participez à la conversation